Welcome to our dedicated page for The Campbell's Company SEC filings (Ticker: CPB), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Campbell's Company (NASDAQ: CPB) files a range of documents with the U.S. Securities and Exchange Commission that provide detailed insight into its operations, governance and capital structure. As a New Jersey-incorporated issuer with capital stock listed on The Nasdaq Stock Market LLC, Campbell's uses SEC filings to report annual and quarterly financial results, material events, shareholder meeting outcomes and executive compensation information.
On this page, users can review Campbell's annual reports on Form 10-K and quarterly reports on Form 10-Q, which describe its two primary divisions, Meals & Beverages and Snacks, outline segment performance, and discuss factors affecting results such as acquisitions, divestitures, cost savings programs, tariffs and consumer trends. These periodic reports also include risk factors, management’s discussion and analysis, and notes on debt, credit facilities and other financial commitments.
Campbell's frequently files current reports on Form 8-K to disclose specific material events. Recent 8-K filings have covered topics such as the pricing and issuance of senior unsecured notes under an automatic shelf registration statement, amendments extending the maturity of a multi-billion dollar credit agreement, the announcement of quarterly and full-year earnings results, executive appointments and transitions in key finance roles, and the results of the annual meeting of shareholders, including director elections and advisory votes on executive compensation.
The company also files a definitive proxy statement on Schedule 14A, which provides information on board nominees, governance practices, executive pay programs and shareholder proposals. Voting results for these matters are then reported in subsequent 8-K filings under Item 5.07.
Through this filings page, users can access Campbell's regulatory disclosures as they are made available on EDGAR. AI-powered tools can help summarize lengthy documents such as 10-Ks, 10-Qs and proxy statements, highlight key items from 8-Ks, and make it easier to understand topics like segment reporting, capital structure changes, cost savings targets and shareholder vote outcomes without reading every page of each filing.
Campbell's Co executive Risa Cretella, EVP and President, M&B, reported a tax-related share disposition involving the company’s Common Stock. 6,543 shares were withheld at $22.27 per share to cover tax obligations. After this transaction, she continues to directly hold 105,120 shares of Campbell's Co stock, indicating this was a routine compensation-related event rather than an open-market trade.
ARREDONDO FABIOLA R reported acquisition or exercise transactions in this Form 4 filing.
CAMPBELL'S Co director Fabiola R. Arredondo received a stock grant of 1,925 shares of common stock on March 30, 2026 at no purchase price. Following this award, she directly holds 31,772 Campbell's common shares, reflecting an increase in her equity stake through compensation, not an open‑market purchase.
Dorrance Bennett JR reported acquisition or exercise transactions in this Form 4 filing.
Campbell's Co director Bennett Dorrance Jr reported an indirect award of 1,925 shares of Common Stock to the Bennett Dorrance, Jr. Trust at $0.00 per share, indicating a compensation-related grant rather than a market purchase. Following this award, the trust holds 572,410 Campbell's shares indirectly attributed to him, so the new grant modestly increases an already substantial indirect position.
Campbell's Co director and major shareholder Mary Alice Dorrance Malone, Jr. reported an indirect acquisition of common stock through a related trust. On March 30, 2026, the Mary Alice Malone, Jr. Management Trust received a grant or other acquisition of 1,882 shares of Campbell's common stock at no stated price, bringing that trust’s holdings to 82,454 shares.
The filing also lists substantial indirect holdings of Campbell's common stock in multiple trusts and entities associated with Ms. Malone, Jr., including large positions held by limited partnerships and limited liability companies where she is a co-manager or beneficiary and in some cases disclaims beneficial ownership except to the extent of her pecuniary interest.
Campbell's Co director Hill Grant received a grant of 3,224 shares of Common Stock at $0.00 per share, reflecting a compensation-related award rather than an open-market purchase. After this award, Grant directly holds 35,244.05 shares of Campbell's Co common stock.
The total includes 438.41 shares acquired through dividend reinvestment since Grant’s prior report, showing ongoing accumulation of stock via the company’s dividend reinvestment mechanism in addition to the new share grant.
vanBeuren Archbold D reported acquisition or exercise transactions in this Form 4 filing.
CAMPBELL'S Co director Archbold D. vanBeuren reported an indirect share award. An entity described as the ADvB Revocable Trust received a grant of 2,037 shares of Campbell's common stock on March 30, 2026 at a stated price of $0.00 per share.
Following this award, that trust held 607,077 shares indirectly. Separate indirect holdings are reported for the ADvB 2016 GRAT, two family management companies, and a Spousal Trust, with footnotes noting that vanBeuren disclaims beneficial ownership of certain securities except to the extent of his pecuniary interest.
Campbell's Co director Howard M. Averill received a grant of 2,051.39 units of Phantom Stock, each economically equivalent to one share of common stock. This award is fully vested and payable in cash from the Company's Supplemental Retirement Plan upon his retirement, resignation or termination.
Following the grant, his Phantom Stock balance totals 36,668.31 units, which includes 483.55 units acquired through dividend reinvestment since his prior report. This transaction reflects a compensation-related award rather than an open-market share purchase or sale.
Schmidt Kurt reported acquisition or exercise transactions in this Form 4 filing.
CAMPBELL'S Co director Kurt Schmidt received a grant of 3,223.620 Phantom Stock units, each economically equivalent to one share of common stock. The phantom shares are fully vested and payable in cash from the Company’s Supplemental Retirement Plan upon his retirement, resignation or termination. Following this grant, Schmidt holds 54,490.370 Phantom Stock units, including 716.12 units accumulated through dividend reinvestment since his last report.
Campbell's Co director Keith R. McLoughlin received a grant of 3,854.82 phantom stock units, each economically equivalent to one share of Campbell's common stock. Following this compensation-related award, he holds a total of 66,479.55 phantom stock units, including 874.77 units acquired through dividend reinvestment. The phantom shares are fully vested and will be settled in cash under the Company’s Supplemental Retirement Plan upon his retirement, resignation, or termination.
Campbell's Co director Maria Teresa Hilado received a grant of 2,037.310 phantom stock units, each economically equivalent to one share of Campbell's common stock. These phantom shares are fully vested and will be paid in cash from the Company's Supplemental Retirement Plan upon her retirement, resignation or termination.
Following this award, she holds a total of 39,275.080 phantom stock units, which includes 520.16 units acquired through dividend reinvestment since her last report.